Evelo Biosciences, Inc.

OTCPK:EVLO 주식 보고서

시가총액: US$1.9k

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Evelo Biosciences 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

최고 경영자

n/a

총 보상

CEO 급여 비율n/a
CEO 임기no data
CEO 소유권n/a
경영진 평균 재임 기간4.4yrs
이사회 평균 재임 기간데이터 없음

최근 관리 업데이트

Recent updates

Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Aug 18
Is Evelo Biosciences (NASDAQ:EVLO) Using Debt In A Risky Way?

Evelo Biosciences GAAP EPS of -$0.40 beats by $0.03

Aug 11

Marella Thorell is the new finance chief of Evelo Biosciences

Jul 18

Evelo Biosciences: Hope After Dilution?

Jun 06

Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Mar 21
Evelo Biosciences (NASDAQ:EVLO) Has Debt But No Earnings; Should You Worry?

Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

Sep 25
Is Evelo Biosciences (NASDAQ:EVLO) Weighed On By Its Debt Load?

What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Mar 11
What Type Of Shareholders Make Up Evelo Biosciences, Inc.'s (NASDAQ:EVLO) Share Registry?

Evelo Bio secures ~$67.5M capital raise

Jan 29

Evelo Biosciences expands EDP1815 mid-stage trial to atopic dermatitis

Jan 07

Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Dec 15
Trade Alert: The Independent Chairman Of Evelo Biosciences, Inc. (NASDAQ:EVLO), David Epstein, Has Just Spent US$51k Buying 77% More Shares

Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Dec 11
Do Institutions Own Evelo Biosciences, Inc. (NASDAQ:EVLO) Shares?

Evelo Biosciences identifies new lead oncology candidate

Dec 09

Evelo Bio's EDP1815 completes enrollment targeting interim data in mid-stage psoriasis study

Dec 03

Evelo Biosciences EPS beats by $0.04

Oct 29

CEO

Evelo Biosciences 에는 CEO가 없거나 그에 대한 데이터가 없습니다.

리더십 팀

이름위치테뉴어보상소유권
Craig Jalbert
Presidentless than a year데이터 없음데이터 없음
Chun Zhang
Chief Technical Operations & Quality Officer4.4yrs데이터 없음데이터 없음
Mark Bodmer
Chief Scientific Officer and President of Research & Development8.3yrsUS$1.15m0.14%
$ 2.6
Jessica Cotrone
VP & Head of Communicationsno data데이터 없음데이터 없음
Leslie Wardwell-Scott
VP and Head of Corporate Development & Strategic Integration2.1yrs데이터 없음데이터 없음
Andrea Itano
Head of Research4.4yrs데이터 없음데이터 없음
Duncan McHale
Chief Medical Officer6.4yrsUS$1.23m0.089%
$ 1.7
Douglas Maslin
Senior Director & Immunology Clinical Leadno data데이터 없음데이터 없음

4.4yrs

평균 재임 기간

62yo

평균 연령

경험이 풍부한 관리: EVLO 의 관리팀은 경험 ( 4.3 년 평균 재직 기간)으로 간주됩니다.